ARTICLE | Distillery Therapeutics
An FGF21, GLP-1 fusion protein for diabetes, obesity
September 30, 2020 8:20 PM UTC
DISEASE CATEGORY: Endocrine/metabolic
INDICATION: Diabetes; obesity...
BCIQ Company Profiles
DISEASE CATEGORY: Endocrine/metabolic
INDICATION: Diabetes; obesity...
BCIQ Company Profiles
BCIQ Company Profiles